Kaletra Campaign News Archive

May 30, 2013- The Jakarta Globe: Future Hepatitis C Blockbusters May Spawn Compulsory Generics (links to thejakartaglobe.com)

March 18, 2013-
ACTION! Essential Inventions issues request for non-voluntary authorization to use patents under Article 14 of Greece patent law (links to essentialinventions.org)

March 17, 2013
-Financial Times: Athens urged to import generic drugs (links to ft.com)

December, 2012
-
Secondary Patenting: A Threat to Affordable Generic Patenting by I-MAK

November 2, 2012- Nature: NIH asked to grant open license on HIV drug (links to blogs.nature.com)

October 22, 2012-The Star (Malaysia): Measure to make drugs affordable (links to thestar.com.my)

October 12, 2012-
Reuters: Indonesia acts to over-ride patents on HIV drugs (links to uk.reuters.com)

Jakarta Globe

CNBC
Chicago Tribune


October 11, 2012-
ACTION! The Guardian: Indonesia in bold move to obtain cheap drugs for HIV (links to guardian.co.uk)
Link to Indonesia action page


August 17, 2012-The Hindu Business Line: Cipla bats for automatic compulsory licensing (link to thehindubusinessline.com)


August 16, 2012
-Pharmalot: Abbott Paid CEO More Than Taxes To Uncle Sam (links to pharmalot.com)


July 24, 2012
-Rep. Henry Waxman: More work needs to be done on HIV (links to Politico) 

May 3, 2012: Pharmalot: Abbott, Kaletra Pricing And AIDS in Colombia (link to pharmalot.com)

March 14, 2012-GTPI supports judicial decision annulling patent HIV/AIDS medicine (link to www.patentes.org.br)

March 14, 2012-Update from Malaysia: Personal Statement on Abbott Laboratories' Kaletra

March 9, 2012-ACTION!: Folha.com: Decisão da Justiça anula patente de droga anti-Aids (link to www1.folha.uol.com.br)
Brazilian court annuls patent on HIV/AIDS medicine (Kaletra) (in Portuguese)

February 29, 2012-ACTION! Colombian 37th Administrative Circuit Court Judge's Sentence for "Acción Popular" (en español)(links to communicacionpositiva.org)
Part 1
   Part 2
Public Citizen: Colombian Court: Abbott Labs' AIDS Drug Pricing Abuse Violated Health Rights

January 10, 2012-ACTION!: Abbott Laboratories responds with letter to the St. Maarten AIDS Foundation

December 21, 2011- ACTION!: Abbott Laboratories' responds with letter to the Vietnam Network of People Living with HIV

December 20, 2011- ACTION!: Working Group on International Property (GTPI) on Brazilian Patent Office's decision to prioritize examination of the patent application related to heat-stable ritonavir and lopinavir/ritonavir (links to deolhonaspatentes.org.br)

December 1, 2011- AIDS Treatment Revolution: Expand Generic Competition (links to truthout.org)

December 1, 2011- Public Citizen World AIDS Day Statement: Expanding Global AIDS Treatment Through Generic Competition

November 22, 2011-ACTION!: See ITPC Indonesia's Letter to the Indonesian Ministry of Health Here (in Indonesian)

November 18, 2011- Celebrating the 10th Anniversary of the Doha Declaration

November 17, 2011-ACTION!: See the Letter to Abbott Laboratories from the Malaysian AIDS Council (MAC) Here

November 17, 2011-ACTION!: See the Letter to Abbott Laboratories from Peruvian Civil Society Groups Here (in Spanish)

November 16, 2011- Global Action To Open Generic Competition For Key AIDS Drug (links to ip-watch.org)

November 10, 2011-MSF: Brazilians demand greater access to crucial HIV drug (links to msfaccess.org)

November 10, 2011-The Guardian: Unprecedented global campaign launches against pharma company (links to guardian.co.uk)

November 10, 2011-Pharmalot: Activists Challenge Abbott Over Its AIDS Drug (links to pharmalot.com)

November 10, 2011-ACTION!: St. Maarten AIDS Foundation sends letter to Abbott Laboratories requesting an open license

November 10, 2011-ACTION!:
Brazil files patent opposition for lopinavir+ritonavir (Kaletra) & ritonavir

November 10, 2011-
ACTION!
: Over 50 Vietnamese civil society organization signatories sent a license request to Abbott Laboratories, and VNP+ sent a license request to the Vietnamese Ministry of Health

November 10, 2011
-ACTION!
: Chinese civil society organizations sent a letter requesting an open license from Abbott Laboratories


November 9, 2011-
Public Health Groups Launch Global Campaign Against Abbott Labs’ Monopoly on Critical AIDS Medicine

June, 2009-
Ashurst: German Supreme Court allows "compulsory licence defence" in patent infringement claim (links to ashurst.com)

March 18, 2008- Florida Sun-Sentinel: Compulsory licenses the right medicine for prescriptions in developing countries (links to essentialaction.org)

June 22, 2007- Kaiser Daily HIV/AIDS Report: New Trade Agreement Language to Allow Developing Countries More Flexibility in Circumventing Drug Patents, Other Restrictions at Access to Medicines Project (links to essentialaction.org)

June 21, 2007-
Congress Daily: New Language Would Give Developing Countries Leeway On Pharmaceuticals (links to essentialaction.org)




Back to Global Kaletra Campaign Main Page

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.